Darren Harvey

Darren is Vice President of Medicinal Chemistry at Twentyeight-Seven, bringing over 20 years of Drug Discovery experience to the team. Darren has held positions of increasing responsibility at both biotech and big pharma, starting his career at Array Biopharma before transitioning to Sanofi and then Epizyme prior to joining 28-7. Darren is passionate about finding novel solutions to impact patients’ lives and working in a fast-paced multidisciplinary organization. Darren did his undergraduate and Ph.D. research in the UK before a 2-year Post Doc at Pitt. Darren is a co-author / co-inventor on >30 peer-reviewed articles and patent applications with 20 published patents.